Patents by Inventor Sean H. Adams

Sean H. Adams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PANCREATIC POLYPEPTIDE FAMILY MOTIFS, POLYPEPTIDES AND METHODS COMPRISING THE SAME
    Publication number: 20150231204
    Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.
    Type: Application
    Filed: November 12, 2014
    Publication date: August 20, 2015
    Inventors: Odile Esther LEVY, Carolyn M. Jodka, Soumitra S. Ghosh, David G. Parkes, Richard A. Pittner, Lawrence J. D'Souza, John S. Ahn, Kathryn S. Prickett, Jonathan David Roth, Sean H. Adams
  • Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
    Patent number: 8906849
    Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.
    Type: Grant
    Filed: April 8, 2013
    Date of Patent: December 9, 2014
    Assignees: Amylin Pharmaceuticals, LLC, AstraZeneca Pharmaceuticals LP
    Inventors: Odile Esther Levy, Carolyn M. Jodka, Soumitra S. Ghosh, David G. Parkes, Richard A. Pittner, Lawrence J. D'Souza, John S. Ahn, Kathryn S. Prickett, Jonathan David Roth, Sean H. Adams
  • PANCREATIC POLYPEPTIDE FAMILY MOTIFS, POLYPEPTIDES AND METHODS COMPRISING THE SAME
    Publication number: 20130303442
    Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.
    Type: Application
    Filed: April 8, 2013
    Publication date: November 14, 2013
    Inventors: Odile Esther LEVY, Carolyn M. Jodka, Soumitra S. Ghosh, David G. Parkes, Richard A. Pittner, Lawrence j. D'souza, John S. Ahn, Kathryn S. Prickett, Jonathan David Roth, Sean H. Adams
  • Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
    Patent number: 8426361
    Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.
    Type: Grant
    Filed: December 17, 2009
    Date of Patent: April 23, 2013
    Assignees: Amylin Pharmaceuticals, LLC, AstraZeneca Pharmaceuticals LP
    Inventors: Odile Esther Levy, Carolyn M. Jodka, Soumitra S. Ghosh, David G. Parkes, Richard A. Pittner, Lawrence J. D'Souza, John S. Ahn, Kathryn S. Prickett, Jonathan David Roth, Sean H. Adams
  • Metabolic biomarkers for diabetes and insulin resistance
    Patent number: 8367359
    Abstract: Disclosed are small molecule metabolites useful as biomarkers for the evaluation and treatment of pre diabetes, diabetes and insulin resistance.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: February 5, 2013
    Assignees: The United States of America, as represented by the Secretary of Agriculture, The Regents of the University of California
    Inventors: Sean H. Adams, Oliver Fiehn
  • Synuclein gamma as a biomarker of obesity and obesity-related disorders
    Patent number: 8110368
    Abstract: Disclosed is a method of identifying ?-synuclein expression, as a biomarker for adiposity and adiposity related disorders. Identification of ?-synuclein expression includes agonists and antagonists thereof which may be used in pharmaceutical compositions for the treatment of adiposity related disorders.
    Type: Grant
    Filed: January 7, 2009
    Date of Patent: February 7, 2012
    Assignee: The United States of America Department of Agriculture, as represented by the Secretary of Agriculture
    Inventors: Sean H. Adams, Pieter J. Oort
  • Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
    Patent number: 7723471
    Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.
    Type: Grant
    Filed: December 12, 2005
    Date of Patent: May 25, 2010
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Odile Esther Levy, Carolyn M. Jodka, Soumitra S. Ghosh, David G. Parkes, Richard A. Pittner, Lawrence J. D'Souza, John S. Ahn, Kathryn S. Prickett, Jonathan David Roth, Sean H. Adams
  • PANCREATIC POLYPEPTIDE FAMILY MOTIFS, POLYPEPTIDES AND METHODS COMPRISING THE SAME
    Publication number: 20100099619
    Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.
    Type: Application
    Filed: December 17, 2009
    Publication date: April 22, 2010
    Applicant: AMYLIN PHARMACEUTICALS, INC.
    Inventors: Odile Esther Levy, Carolyn M. Jodka, Soumitra S. Ghosh, David G. Parkes, Richard A. Pittner, Lawrence J. D'Souza, John S. Ahn, Kathryn S. Prickett, Jonathan David Roth, Sean H. Adams
  • Control of metabolism with human 2-oxoglutarate carrier
    Patent number: 7141421
    Abstract: The present invention is directed to compositions and methods related to the use of human OGC as an uncoupling protein.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: November 28, 2006
    Assignee: Genentech, Inc.
    Inventors: Sean H. Adams, Xing Xian Yu
  • BFIT compositions and methods of use
    Publication number: 20030220238
    Abstract: Isolated polynucleotides encoding brown fat inducible thioesterase (BFIT) polypeptides and the polypeptides are provided. Methods of using these polynucleotides and polypeptides are also provided.
    Type: Application
    Filed: January 22, 2002
    Publication date: November 27, 2003
    Inventors: Sean H. Adams, Clarissa J. Chui, Audrey D. Goddard, J. Christopher Grimaldi, David A. Lewin
  • Compositions and methods for adipose abundant protein
    Publication number: 20030113327
    Abstract: An isolated polypeptide comprising an amino acid sequence having at least 80% sequence identity to the sequence SEQ ID NOS:4 or 6, polynucleotides encoding these peptides, and antibodies to the polypeptides are useful in treating metabolic disorders or disorders associated with changes in adipose tissue physiological function or mass.
    Type: Application
    Filed: May 24, 2002
    Publication date: June 19, 2003
    Inventor: Sean H. Adams
  • FIZZ1 for metabolism regulation
    Publication number: 20030104351
    Abstract: A method of increasing metabolic activity in a subject comprises increasing the activity of FIZZ1.
    Type: Application
    Filed: March 29, 2002
    Publication date: June 5, 2003
    Inventor: Sean H. Adams
  • CGI-69 compositions and methods of use
    Publication number: 20020119137
    Abstract: An isolated polypeptide comprising an amino acid sequence having at least 80% sequence identity to the sequence SEQ ID NO:1, polynucleotides encoding these peptides, and antibodies to the polypeptides are useful in treating metabolic disorders or disorders associated with changes in adipose tissue physiological function or mass.
    Type: Application
    Filed: June 22, 2001
    Publication date: August 29, 2002
    Inventors: Sean H. Adams, David Lewin, Xing Xian Yu
  • Control of metabolism with human 2-oxoglutarate carrier
    Publication number: 20020103150
    Abstract: The present invention is directed to compositions and methods related to the use of human OGC as an uncoupling protein.
    Type: Application
    Filed: June 22, 2001
    Publication date: August 1, 2002
    Inventors: Sean H. Adams, Xing Xian Yu